A58.F · Anthem, Inc

-

Please sign in to comment on A58.F

1 Comment

Admin

3 years, 7 months ago

Anthem, Inc is currently in a long term uptrend where the price is trading 16.1% above its 200 day moving average.

From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 0.8.

Anthem, Inc's total revenue rose by 16.1% to $32B since the same quarter in the previous year.

Its net income has dropped by 41.0% to $551M since the same quarter in the previous year.

Finally, its free cash flow grew by 262.2% to $4B since the same quarter in the previous year.

Based on the above factors, Anthem, Inc gets an overall score of 4/5.

Industry	Healthcare Plans
Sector	Healthcare
Exchange	F
ISIN	US0367521038
CurrencyCode	EUR

Target Price	436
PE Ratio	19.71
Market Cap	107B
Beta	0.86
Dividend Yield	1.2%

ABOUT

Anthem, Inc

Elevance Health, Inc. operates as a health benefits company. The company operates through four segments: Commercial & Specialty Business, Government Business, CarelonRx, and Other. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was founded in 1944 and is based in Indianapolis, Indiana.

A58.F · Anthem, Inc

-

Anthem, Inc

Earnings

Valuation

Cash Flow

Profitability

Performance

Backtest Anthem, Inc using a moving average strategy